Skip Nav Destination
Issues
1 March 2014
-
Cover Image
Cover Image
STAT3 and NF-κB signaling pathways are often simultaneously activated in neoplastic cells and play important roles in tumorigenesis and drug sensitivity. TPCA-1, a previously found antagonist of IKKs, blocks STAT3 anchoring to upstream tyrosine kinase and inhibits STAT3 activation induced by cytokines and c-Src. Molecular modeling indicates that TPCA-1 is well docked into SH2 domain of STAT3 and formed hydrogen bond with Glu594. As a direct inhibitor of STAT3 and IKKs, TPCA-1 inhibits growth of non–small cell lung cancer (NSCLC) with EGFR mutation and potentiates the antitumor effect of gefitinib. For details, see article by Nan and colleagues on page 617.Close Modal - PDF Icon PDF LinkTable of Contents
ISSN 1535-7163
EISSN 1538-8514
Highlights
Hypothesis/Commentary
Small Molecule Therapeutics
A Novel Small-Molecule Inhibitor of Mcl-1 Blocks Pancreatic Cancer Growth In Vitro and In Vivo
Fardokht Abulwerdi; Chenzhong Liao; Meilan Liu; Asfar S. Azmi; Amro Aboukameel; Ahmed S.A. Mady; Thippeswamy Gulappa; Tomasz Cierpicki; Scott Owens; Tao Zhang; Duxin Sun; Jeanne A. Stuckey; Ramzi M. Mohammad; Zaneta Nikolovska-Coleska
Author Choice
Combined MET Inhibition and Topoisomerase I Inhibition Block Cell Growth of Small Cell Lung Cancer
Cleo E. Rolle; Rajani Kanteti; Mosmi Surati; Suvobroto Nandi; Immanuel Dhanasingh; Soheil Yala; Maria Tretiakova; Qudsia Arif; Todd Hembrough; Toni M. Brand; Deric L. Wheeler; Aliya N. Husain; Everett E. Vokes; Ajit Bharti; Ravi Salgia
The Fatty Acid Synthase Inhibitor Orlistat Reduces the Growth and Metastasis of Orthotopic Tongue Oral Squamous Cell Carcinomas
Michelle Agostini; Luciana Y. Almeida; Débora C. Bastos; Rose M. Ortega; Fernanda S. Moreira; Fabiana Seguin; Karina G. Zecchin; Helena F. Raposo; Helena C.F. Oliveira; Nivea D. Amoêdo; Tuula Salo; Ricardo D. Coletta; Edgard Graner
Large Molecule Therapeutics
Cancer Biology and Signal Transduction
Tools and Technologies
Author Choice
Cancer-Associated CD43 Glycoforms as Target of Immunotherapy
Franca Maria Tuccillo; Camillo Palmieri; Giuseppe Fiume; Annamaria de Laurentiis; Marco Schiavone; Cristina Falcone; Enrico Iaccino; Ricciarda Galandrini; Cristina Capuano; Angela Santoni; Francesco Paolo D'Armiento; Claudio Arra; Antonio Barbieri; Fabrizio Dal Piaz; David Venzon; Patrizia Bonelli; Franco Maria Buonaguro; Iris Scala; Massimo Mallardo; Ileana Quinto; Giuseppe Scala
Letters to the Editor
Advertisement